EUROSTARS: A German SME is seeking partners with expertise in oncology, femto-second-laser technique, and medical software development to build a prototype of a patented laser-based cell disruption technology for the anti-tumour immune therapy.
A German diagnostic SME has developed a patented laser-based cell disruption technology for the anti-tumour immune therapy. The technology allows the extraction of the intra-cellular anti-gene structure of the tumour cells, which is chemically unchanged and enables an efficient stimulation of the immune response and vaccination. A project proposal shall be drafted for the next cut-off in February 2020. At least one SME and further partners are sought for research cooperation agreements.